Related references
Note: Only part of the references are listed.Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin
Sunder Mudaliar et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Luseogliflozin for the treatment of type 2 diabetes
Yutaka Seino
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
Aurora Merovci et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action
Yoshihito Fujita et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Ketoacidosis during a low-carbohydrate diet
P Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Efficacy and safety of low-carbohydrate diets - A systematic review
DM Bravata et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Management of hyperglycemic crises in patients with diabetes
AE Kitabchi et al.
DIABETES CARE (2001)
Share Paper
